MyFinsight
Home
Blog
About
Marketable securities
$364,457K
(96.87%↑ Y/Y)
Cash and cash
equivalents
$54,124K
(36.05%↑ Y/Y)
Prepaid expenses and
other current assets
$9,281K
(116.64%↑ Y/Y)
Total property and
equipment
$5,476K
(139.13%↑ Y/Y)
Total current assets
$427,862K
(86.68%↑ Y/Y)
Property and equipment,
net
$4,663K
(169.54%↑ Y/Y)
Right-of-use assets
$2,759K
(400.73%↑ Y/Y)
Other assets
$625K
(1150.00%↑ Y/Y)
Less accumulated
depreciation
$813K
(45.18%↑ Y/Y)
Total assets
$435,909K
(88.28%↑ Y/Y)
Total liabilities and
stockholders' equity
$435,909K
(88.28%↑ Y/Y)
Total stockholders'
equity
$409,539K
(86.80%↑ Y/Y)
Total liabilities
$26,370K
(114.69%↑ Y/Y)
Accumulated deficit
-$285,088K
(-57.68%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$1,222K
(-11209.09%↓ Y/Y)
Additional
paid-in-capital
$695,843K
(73.95%↑ Y/Y)
Total current
liabilities
$23,660K
(101.26%↑ Y/Y)
Operating lease
liabilities, net of current
$2,710K
(429.30%↑ Y/Y)
Common stock, 0.0001
par value,...
$6K
(20.00%↑ Y/Y)
Accrued expenses
$18,673K
(218.98%↑ Y/Y)
Accounts payable
$4,356K
(-24.43%↓ Y/Y)
Operating lease
liabilities, current
$631K
(357.25%↑ Y/Y)
Back
Back
Balance Sheet
MBX Biosciences, Inc. (MBX)
MBX Biosciences, Inc. (MBX)
source: myfinsight.com